Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REPROS THERAPEUTICS INC. (RPRX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-17 | Jun-30-17 | Mar-31-17 | Dec-31-16 | Sep-30-16 | Jun-30-16 | Mar-31-16 | Dec-31-15 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 2285.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | -2185.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 322.0% | 16285.7% | 29628.6% | 42700.0% | 31820.0% | 21620.0% | 22147.1% | 60487.5% |
| General and administrative | 309.2% | 12942.9% | 54900.0% | 23716.7% | 9970.0% | 7013.3% | 6447.1% | 18000.0% |
| Depreciation | 0.3% | 14.3% | 14.3% | 16.7% | 10.0% | 6.7% | 11.8% | 37.5% |
| EBIT | -437.2% | -29228.6% | -84528.6% | -66416.7% | -41790.0% | -28633.3% | -28594.1% | -78487.5% |
| Pre-tax income | -531.3% | -31414.3% | -84428.6% | -66316.7% | -41690.0% | -28533.3% | -28494.1% | -78387.5% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -531.3% | -31414.3% | -84428.6% | -66316.7% | -41690.0% | -28533.3% | -28494.1% | -78387.5% |
|